Correction: Activation of notch signaling is required for cholangiocarcinoma progression and is enhanced by inactivation of P53 in vivo (PLoS ONE (2013) 8:10 (e77433) DOI: 10.1371/journal.pone.0077433

0Citations
Citations of this article
4Readers
Mendeley users who have this article in their library.

Abstract

Notice of republication This article [1] was republished on October 22, 2018 to address concerns raised post-publication regarding the Figs 3, 4, and 5. The image presented for the DMSO/SZ1 experiment in Fig 3A was duplicated from a previous publication (Fig 5A in [2]). In Fig 4, duplicate images were shown for SZ1 treated with DMSO and 5μMGSI IX, and the wrong image was shown for the 20μMpanel. In Fig 5, duplicate images were presented in the "Snail" and "E cadherin" panels of Fig 5A and Fig 5B, and the molecular weight labels for these panels in Fig 5B were incorrect. The University of Tuebingen investigated these issues and did not find evidence of misconduct. The authors apologize for the errors in the original publication [1] and have provided corrected versions of the above figures which are included in the republished version. In addition, the raw blot images for Fig 5 are now provided in Supporting Information (S1 File). Please download this article again to view the correct version. Supporting information S1 File. Raw blots for Fig 5. (PPT).

Cite

CITATION STYLE

APA

El Khatib, M., Bozko, P., Palagani, V., Malek, N. P., Wilkens, L., & Plentz, R. R. (2018, November 1). Correction: Activation of notch signaling is required for cholangiocarcinoma progression and is enhanced by inactivation of P53 in vivo (PLoS ONE (2013) 8:10 (e77433) DOI: 10.1371/journal.pone.0077433. PLoS ONE. Public Library of Science. https://doi.org/10.1371/journal.pone.0206953

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free